News

Filter

Current filters:

LyricaEli Lilly

Lilly/Boehringer Ingelheim's Cymbalta now fibromyalgia market leader in USA

22-07-2012

US drug major Eli Lilly (NYSE: LLY) and German independent Boehringer Ingelheim's Cymbalta (duloxetine)…

Boehringer IngelheimCymbaltaEli LillyGlobalLyricaMarkets & MarketingNeurologicalNorth AmericaPfizerPharmaceutical

Global pain management drugs market to see moderate growth as generic share continues to rise

24-11-2011

In 2010, the global pain management market was worth approximately $28.6 billion, representing a compound…

CelebrexCymbaltaEli LillyGlobalLyricaMarkets & MarketingNeurologicalPfizerPharmaceutical

COMPANY SPOTLIGHT

Menarini

Back to top